Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medstone MEDS -- Ignore unavailable to you. Want to Upgrade?

To: Douglas Craig who wrote (2)	1/13/1998 3:46:00 PM
From: Richard V.	Read Replies (1) \| Respond to of 8

Doug, I am also a holder of Urogen and have tried numerous times to contact them at (619) 450-5949 and have left three messages to Paul Quadros (COB), as of this date I have still not heard from them. When you call Medstone they will only refer you to the above phone number. Why don't you give it a try and let me know your results. Richard e-mail:rvoit@micron.net

To: Douglas Craig who wrote (2)	8/15/1998 7:32:00 PM
From: Elliot Lepler	Read Replies (1) \| Respond to of 8

I was nosing around and found this note. Urogen now trades under symbol UROG. Silicon Investor has a separate subject for this very interesting undiscovered entity. Urogen has contracted with Baxter Laboratories and his hired as the new CEO a proven performer. Genentech markets his last product. Amazing this company trades with a market value of something like $10 million. As soon as they publicize the research that has already been done, I am sure the market will multiply that number several times. Take a look and post on the Urogen thread.